Complementary hypotheses in safety surveillance
From MaRDI portal
Publication:4965656
Recommendations
- A maximized sequential probability ratio test for drug and vaccine safety surveillance
- Continuous post-market sequential safety surveillance with minimum events to signal
- scientific article; zbMATH DE number 1154646
- Continuous versus group sequential analysis for post-market drug and vaccine safety surveillance
- Type I error probability spending for post-market drug and vaccine safety surveillance with Poisson data
Cites work
- scientific article; zbMATH DE number 1348603 (Why is no real title available?)
- scientific article; zbMATH DE number 2201473 (Why is no real title available?)
- scientific article; zbMATH DE number 3045589 (Why is no real title available?)
- A maximized sequential probability ratio test for drug and vaccine safety surveillance
- Closed sequential tests for binomial probabilities
- Continuous versus group sequential analysis for post-market drug and vaccine safety surveillance
- ON A METHOD OF ESTIMATING FREQUENCIES
- On a method of estimating frequencies
- One-sided tests in clinical trials with multiple endpoints
- Planning and Monitoring of Equivalence Studies
- Power, sample size and adaptation considerations in the design of group sequential clinical trials
- Sequential Tests of Statistical Hypotheses
- Type I error probability spending for post-market drug and vaccine safety surveillance with Poisson data
This page was built for publication: Complementary hypotheses in safety surveillance
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4965656)